Chronic brain inflammation results in cell loss in the entorhinal cortex and impaired LTP in perforant path-granule cell synapses

Experimental Neurology

Volumn 176, Issue 2, 2002, Pages 336-341

  Hauss Wegrzyniak, B ^a   Lynch, M A ^b   Vraniak, P D ^a   Wenk, G L ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Chronic neuroinflammation; Hippocampus; LTP; Rats; Stereology

Indexed keywords

LIPOPOLYSACCHARIDE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; BRAIN FOURTH VENTRICLE; CELL LOSS; CONTROLLED STUDY; DEMENTIA; DENTATE GYRUS; ENCEPHALITIS; ENTORHINAL CORTEX; GRANULE CELL; HIPPOCAMPUS; HISTOPATHOLOGY; LONG TERM POTENTIATION; MALE; NERVE CELL PLASTICITY; NONHUMAN; PERFORANT NERVE TRACT; PERIKARYON; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; STEREOLOGY; TEMPORAL LOBE;

EID: 0036403097     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2002.7966     Document Type: Article

References (43)

1. Aisen, P. S., and K. L. Davis. 1994. Inflammatory mechanisms in Alzheimer's Disease: implications for therapy. Am. J. Psychiat. 151: 1105-1113.
2. Akiyama, H., S. Barger, S. Barnum, B. Bradt, J. Bauer, N. R. Cooper, P. Eikelenboom, M. Emmerling, B. Fiebich, C. E. Finch, S. Frautschy, W. S. T. Griffin, H. Hampel, G. Landreth, P. L. McGeer, R. Mrak, I. MacKenzie, K. O'Banion, J. Pachter, G. Pasinetti, C. Plata-Salaman, J. Rogers, R. Rydel, Y. Shen, W. Streit, R. Strohmeyer, I. Tooyoma, F. L. Van Muiswinkel, R. Veerhuis, D. Walker, S. Webster, B. Wegrzyniak, G. Wenk, and A. Wyss-Coray. 2000. Inflammation in Alzheimer's disease. Neurobiol. Aging 21: 383-421.
3. Ball, M. J., V. Hachinski, A. Fox, A. J. Kirshen, M. Fishman, W. Blume, V. A. Kral, and H. Fox. 1986. A new definition of Alzheimer's disease: A hippocampal dementia. Lancet 1: 111-118.
4. Bliss, T. V. P., and A. R. Gardner-Medwin. 1973. Long-lasting potentiation of synaptic transmission in the dentate area of the un-anesthetized rabbit following stimulation of the perforant path. J. Physiol. (London) 232: 357-374.
5. Bliss, T. V. P., and T. Lømo. 1973. Long-lasting potentiation of synaptic transmission in the dentate area of the un-anesthetized rabbit following stimulation of the perforant path. J. Physiol. (London) 232: 331-336.
6. Cagnin, A., D. J. Brooks, A. M. Kennedy, R. N. Gunn, R. Myers, and F. E. Turkheimer. 2001. In vivo measurement of activated microglia in dementia. Lancet 358: 461-467.
7. Chao, C. C., and S. Hu. 1994. Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures. Dev. Neurosci. 16: 172-179.
8. Cipolotti, L., T. Shallice, D. Chan, N. Fox, R. Scahill, G. Harrison, J. Stevens, and P. Rudge. 2001. Long-term retrograde amnesia . . . the crucial role of the hippocampus. Neuropsychol. 39: 151-172.
9. Cunningham, A. J., C. A. Murray, L. A. J. O'Neill, M. A. Lynch, and J. J. O'Connor. 1996. Interleukin-1 and tumour necrosis factor inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci. Lett. 203: 17-20.
10. Eikelenboom, P., J. M. Roxemuller, and F. L. van Muiswinkel. 1998. Inflammation and Alzheimer's disease: relationships between pathogenic mechanisms and clinical expression. Exp. Neurol. 154: 89-98.
11. Eikelenboom, P., S. S. Zhan, A. van Gool, and D. Allsop. 1994. Inflammatory mechanisms in Alzheimer's disease. TIPS 15: 447-450.
12. Griffin, W. S. T., L. C. Stanley, C. Ling, L. White, V. MacLeod, L. J. Perrot, C. L. White, 3rd, and C. Araoz. 1998. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down Syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA 86: 7611-7615.
13. Hauss-Wegrzyniak, B., P. Dobrzanski, J. D. Stoerh, and G. L. Wenk. 1998. Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease. Brain Res. 780: 294-303.
14. Hauss-Wegrzyniak, B., J.-P. Galons, and G. L. Wenk. 2000. Quantitative volumetric analyses of brain magnetic resonance imaging from rat with chronic neuroinflammation. Exp. Neurol. 165: 347-354.
15. Hauss-Wegrzyniak, B., P. Vraniak, and G. L. Wenk. 1999. The effects of a novel NSAID upon chronic neuroinflammation are age dependent. Neurobiol. Aging 20: 305-313.
16. Hauss-Wegrzyniak, B., L. B. Willard, G. Pepeu, P. Del Soldato, and G. L. Wenk. 1999. Peripheral administration of novel anti-inflammatories can attenuate the effects of chronic inflammation within the CNS. Brain Res. 815: 36-43.
17. Hauss-Wegrzyniak, B., M. G. Vannucchi, and G. L. Wenk. 2000. Behavioral and ultrastructural changes induced by chronic neuroinflammation in young rats. Brain Res. 859: 157-166.
18. Hyman, B. T., G. W. Van Hoesen, and A. R. Damasio. 1990. Memory-related systems in Alzheimer's disease: An anatomic study. Neurology 40: 1721-1730.
19. Hyman, B. T., G. W. Van Hoesen, L. J. Kromer, and A. R. Damasio. 1986. Perforant pathway changes and the memory impairment of Alzheimer's disease. Ann. Neurol. 20: 472-481.
20. Katsuki, H., S. Nakai, Y. Hirai, K. Akaji, Y. Kiso, and M. Satoh. 1990. Interleukin-1 β inhibits long-term potentiation in the CA3 region of mouse hippocampal slices. Eur. J. Pharmacol. 181: 323-326.
21. McGahon, B., and M. A. Lynch. 1996. The synergism between metabotropic glutamate receptor activation and arachidonic acid on glutamate release is occluded by induction of long-term potentiation in dentate gyrus. Neuroscience 72: 847-855.
22. McGeer, P. L., H. Akiyama, S. Itagaki, and E. G. McGeer. 1989. Immune system response in Alzheimer's disease. Can. J. Neurol. Sci. 16: 516-527.
23. McGeer, P. L., and E. McGeer. 1999. Inflammation of the brain in Alzheimer's disease: Implications for therapy. J. Leukocyte Biol. 65: 409-415.
24. Murray, C. A., and M. A. Lynch. 1998. Evidence that increased hippocampal expression of the cytokine interleukin-1 β is a common trigger for age- and stress-induced impaiments in long-term potentiation. J. Neurosci. 18: 2974-2981.
25. Mrak, R. E., J. G. Sheng, and W. S. T. Griffin. 1995. Glial cytokines in Alzheimer's disease: Review and pathogenic implications. Hum. Pathol. 26: 816-823.
26. Prasad, K. N., A. R. Hovland, F. LaRosa, and P. G. Hovland. 1998. Prostaglandins as putative neurotoxins in Alzheimer's disease. Proc. Soc. Exp. Biol. Med. 219: 120-125.
27. Quan, N., S. K. Sundar, and J. M. Weiss. 1994. Induction of interleukin-1 in various brain regions after peripheral and central injections of lipopolysaccharide. J. Neuroimmunol. 49: 125-134.
28. Robinson, M. B., S. Djali, and J. R. Buchhalter. 1993. Inhibition of glutamate uptake with L-transpyrrolidine-2,4-dicarboxylate potentiates glutamate neurotoxicity in primary hippocampal cultures. J. Neurochem. 61: 2099-2103.
29. Rogers, J., S. Webster, F. Lue, L. Brachova, W. H. Civin, M. Emmerling, B. Shivers, D. Walker, and P. McGeer. 1996. Inflammation and Alzheimer's disease pathogenesis. Neurobiol. Aging 17: 681-686.
30. Rothstein, J. D., L. Jin, M. Dykes-Hoberg, and R. W. Kuncl. 1993. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc. Natl. Acad. Sci. USA 90: 6591-6595.
31. Schneider, H., F. Pitossi, D. Balschun, A. Wagner, A. Del Rey, and H. O. Besedovsky. 1998. A neuromodulatory role of interleukin-1 β in the hippocampus. Proc. Natl. Acad. Sci. USA 95: 7778-7783.
32. Tancredi, V., G. D'Arcangelo, F. Grassi, P. Tarroni, G. Palmieri, A. Santoni, and F. Eusebi. 1992. Tumor necrosis factor alters synaptic transmission in rat hippocampal slices. Neurosci. Lett. 146: 176-178.
33. Van Hoesen, G. W., B. T. Hyman, and A. R. Damasio. 1991. Entorhinal cortex pathology in Alzheimer's disease. Hippocamp. 1: 1-8.
34. Vereker, E., V. Campbell, E. Roche, E. McEntee, and M. A. Lynch. 2000. Lipopolysaccharide inhibits long-term potentiation in the rat dentate gyrus by activating caspase-1. J. Biol. Chem. 275: 26252-26258.
35. Vereker, E., E. O'Donnell, and M. A. Lynch. 2000. The inhibitory effect of interleukin-1 β on long term potentiation is coupled with increased activity of stress-activated protein kinases. J. Neurosci. 20: 6811-6819.
36. Wenk, G. L., B. Hauss-Wegrzyniak, and L. B. Willard. 2000. Pathological and biochemical studies of chronic neuroinflammation may lead to therapies for Alzheimer's Disease, In Neuro-Immune Interactions: Proceedings of IPSEN Foundation Meeting, Paris (P. Patterson, C. Kordon, and Y. Christen, Eds.), pp. 73-77. Springer-Verlag, New York.
37. Wenk, G. L., and B. Hauss-Wegrzyniak. 2001. Animal models of chronic neuroinflammation as a model of Alzheimer's Disease, In Inflammatory Events in Neurodegeneration (S. Bondy, and A. Campbell, Eds.), pp. 83-87. Prominent Press, Scottsdale, AZ.
38. Wenk, G. L., and L. B. Willard. 1998. The neural mechanisms underlying cholinergic cell death within the basal forebrain. Int. J. Dev. Neurosci. 16: 729-735.
39. West, M. J., and H. J. G. Gundersen. 1990. Unbiased stereological estimation of the number of neurons in the human hippocampus. J. Comp. Neurol. 190: 1-22.
40. West, M. J. 1993. New stereological methods for counting neurons. Neurobiol. Aging 14: 275-285.
41. West, M. J. 1999. Stereological methods for estimating the total number of neurons and synapses: Issues of precision and bias. Trends Neurosci. 22: 51-61.
42. Zhu, S. G., J. G. Sheng, R. A. Jones, M. M. Brewer, X. Q. Zhou, R. E. Mrak, and W. S. T. Griffin. 1999. Increased interleukin-1 β converting enzyme expression and activity in Alzheimer disease. J. Neuropath. Exp. Neurol. 58: 582-587.
43. Zola-Morgan, S., L. R. Squire, and D. G. Amaral. 1986. Human amnesia and the medial temporal region: Enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus. J. Neurosci. 6: 2950-2967.